|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Inventory | |||||||||||||||||||
| Tax receivable | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Assets held for sale | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Right of use assets, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Deferred tax asset | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||||
| Current portion of lease liabilities | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued income taxes | |||||||||||||||||||
| Accrued and other current liabilities | |||||||||||||||||||
| Liabilities related to assets held for sale | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt, net | |||||||||||||||||||
| Long-term portion of financing obligation | |||||||||||||||||||
| Long-term portion of lease liabilities | |||||||||||||||||||
| Deferred tax liability | |||||||||||||||||||
| Commercial rights liabilities | |||||||||||||||||||
| Other long-term liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||||
| Common stock ($0.01 par value, 200,000,000 shares authorized; 48,988,040 (Successor) and 48,524,809 (Successor) shares issued; 48,988,040 (Successor) and 48,524,809 (Successor) shares outstanding) | |||||||||||||||||||
| Preferred stock ($0.01 par value; 10,000,000 shares authorized; no shares outstanding) | |||||||||||||||||||
| Additional paid-in-capital | |||||||||||||||||||
| Treasury stock, at cost | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||||||
| Total Bally’s Corporation stockholders’ equity | |||||||||||||||||||
| Non-controlling interest | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
| Common stock par value (in dollars per share) | |||||||||||||||||||
| Common Stock, Shares Authorized | |||||||||||||||||||
Loading...
